Finance

Lists
Why is IBO up 2,18%?
Dive Deeper
IBO:NYSEAMERICAN
Impact Biomedical Inc
4,21 $
+2,18%
(+0,090) 1D
9 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBO...
Open
4,13 $
High
4,39 $
Low
4,13 $
Mkt. cap
35,97 млн
Volume
4,02 мың
52-wk high
10,47 $
52-wk low
4,06 $
EPS
-1,13 $
Shares outstanding
8,54 млн
No. of employees
2
Open
4,13 $
High
4,39 $
Low
4,13 $
Mkt. cap
35,97 млн
Volume
4,02 мың
52-wk high
10,47 $
52-wk low
4,06 $
EPS
-1,13 $
Shares outstanding
8,54 млн
No. of employees
2
News stories
From web sources and news partners
About Impact Biomedical Inc
CEO-
Employees2
Founded2018
HeadquartersХьюстон, Техас, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
18,00 мың
7,00 мың
7,00 мың
3,00 мың
Cost of goods sold
1,00 мың
422,00 м.
-
1,00 мың
Cost of revenue
1,00 мың
422,00 м.
-
1,00 мың
Research and development expenses
52,00 мың
110,00 м.
46,00 мың
76,00 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
516,00 м.
275,00 м.
1,90 млн
277,00 м.
Operating expense
965,00 м.
743,00 м.
2,30 млн
704,00 м.
Total operating expenses
966,00 м.
1,16 млн
2,30 млн
705,00 м.
Operating income
-948,00 м.
-1,16 млн
-2,29 млн
-702,00 м.
Other non operating income
-268,00 м.
3,82 млн
-
-
EBT including unusual items
-1,48 млн
2,66 млн
-2,28 млн
-700,00 м.
EBT excluding unusual items
-1,48 млн
2,67 млн
-2,28 млн
-700,00 м.
Income tax expense
-
-2,58 млн
-
-
Effective tax rate
-
-97,18%
-
-
Other operating expenses
109,00 м.
72,00 мың
67,00 мың
67,00 мың
Net income
-1,47 млн
5,24 млн
-2,29 млн
-699,00 м.
Net profit margin
-8 166,67%
74 928,57%
-32 671,43%
-23 300,00%
Earnings per share
-
-
-
-
Interest and investment income
3,00 мың
3,00 мың
5,00 мың
2,00 мың
Interest expense
-262,00 м.
-
-
-
Net interest expenses
-259,00 м.
3,00 мың
5,00 мың
2,00 мың
Depreciation and amortization charges
288,00 м.
286,00 м.
285,00 м.
284,00 м.
EBITDA
-92,00 мың
-872,00 м.
-2,00 млн
-418,00 м.
Gain or loss from assets sale
-
12,00 мың
-
-
AI content may include mistakes. Learn more
Google қолданбалары